Stitcher for Podcasts

Get the App Open App
Bummer! You're not a
Stitcher Premium subscriber yet.
Learn More
Start Free Trial
$4.99/Month after free trial

Show Info

Episode Info

Episode Info:

Host Erik Torenberg talks to Jo Varshney, founder of VeriSIM Life, a Village portfolio company, and Eric Stefanich, director and senior scientist at Genentech.

They explain how VeriSIM is changing drug discovery and development and why more and more drugs are being developed "in silico." They also discuss how startups can work in harmony with big companies and how big pharma has become much more forward-thinking than it is usually given credit for. Erik asks what opportunities they would be looking at if they were a VC in the space right now and how software-as-a-service (SaaS) in pharmaceuticals has evolved. They also discuss dealing with different types of investors when you're starting a biotech company.

Thanks for listening — if you like what you hear, please review us on your favourite podcast platform.

Check us out on the web at or get in touch with us on Twitter @villageglobal.

Read more »

Discover more stories like this.

Like Stitcher On Facebook


Episode Options

Listen Whenever

Similar Episodes

Related Episodes